Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) have received an average recommendation of “Hold” from the six research firms that are currently covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $117.00.
A number of research analysts recently issued reports on CHEOY shares. Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Jefferies Financial Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price for the company. in a research note on Thursday, July 16th. Finally, UBS Group cut CochLear from a “strong-buy” rating to a “hold” rating in a report on Thursday, April 23rd.
Check Out Our Latest Stock Analysis on CHEOY
CochLear Stock Up 0.5%
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than CochLear
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
